|
|
|
|
|
|
|
|
|
22.08.25 - 15:42
|
Wes Streeting′s row with pharma firms grows as talks end on NHS drug pricing (The Guardian)
|
|
|
Drugmakers reject health secretary's latest offer, meaning 'unsustainable' rebate scheme will stay in placeBusiness live – latest updatesA row between Wes Streeting and pharmaceutical companies has intensified after drugmakers rejected the health secretary's latest offer on NHS drug pricing.Talks broke up without agreement on Friday, meaning the mechanism under which the health service claws back some of the money it pays for medicines will continue at a rate the industry has called “unsustainable” and says could discourage companies from making investments in the UK. Continue reading......
|
|
|
|
|
|
|
|
|
|
|
22.08.25 - 05:48
|
Experte für höhere Arzneimittel-Zuzahlungen (DPA-AFX)
|
|
|
BERLIN (dpa-AFX) - Höhere Zuzahlungen zu verschreibungspflichtigen Medikamenten könnten nach Ansicht eines Gesundheitsökonomen den erwarteten Beitragsanstieg in der Krankenversicherung dämpfen. Der Wissenschaftler Wolfgang Greiner schlug in den Zeitungen ......
|
|
|
22.08.25 - 02:06
|
China′s rise in biotech could lower healthcare costs, investor says (SCMP)
|
|
|
China's rise in biotech innovation offers the world a potentially cheaper alternative to costly healthcare products from Western suppliers, but geopolitical tensions remain a major challenge for the country's globalisation efforts, according to a local investor in the sector.
“We can lower the cost of healthcare and benefit more people through technological innovation and efficiency improvement,” Da Liu, managing director of CR-CP Life Science Fund, said in an interview with the Post earlier......
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
